These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 29604489)
1. Attenuation of TNF-induced neutrophil adhesion by simvastatin is associated with the inhibition of Rho-GTPase activity, p50 activity and morphological changes. Antoniellis Silveira AA; Dominical VM; Morelli Vital D; Alves Ferreira W; Trindade Maranhão Costa F; Werneck CC; Ferreira Costa F; Conran N Int Immunopharmacol; 2018 May; 58():160-165. PubMed ID: 29604489 [TBL] [Abstract][Full Text] [Related]
2. TNF induces neutrophil adhesion via formin-dependent cytoskeletal reorganization and activation of β-integrin function. Silveira AAA; Dominical VM; Almeida CB; Chweih H; Ferreira WA; Vicente CP; Costa FTM; Werneck CC; Costa FF; Conran N J Leukoc Biol; 2018 Jan; 103(1):87-98. PubMed ID: 28798145 [TBL] [Abstract][Full Text] [Related]
3. Simvastatin abrogates inflamed neutrophil adhesive properties, in association with the inhibition of Mac-1 integrin expression and modulation of Rho kinase activity. Silveira AA; Dominical VM; Lazarini M; Costa FF; Conran N Inflamm Res; 2013 Feb; 62(2):127-32. PubMed ID: 23250325 [TBL] [Abstract][Full Text] [Related]
4. Heme induces significant neutrophil adhesion in vitro via an NFκB and reactive oxygen species-dependent pathway. Miguel LI; Leonardo FC; Torres LS; Garcia F; Mendonça R; Ferreira WA; Gotardo ÉMF; Fabris FCZ; Brito PL; Costa FF; Conran N Mol Cell Biochem; 2021 Nov; 476(11):3963-3974. PubMed ID: 34191232 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948 [TBL] [Abstract][Full Text] [Related]
6. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Haslinger B; Kleemann R; Toet KH; Kooistra T Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293 [TBL] [Abstract][Full Text] [Related]
8. Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatin. Canalli AA; Proença RF; Franco-Penteado CF; Traina F; Sakamoto TM; Saad ST; Conran N; Costa FF Haematologica; 2011 Apr; 96(4):526-33. PubMed ID: 21173096 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
10. Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Choi M; Rolle S; Rane M; Haller H; Luft FC; Kettritz R Kidney Int; 2003 Jan; 63(1):96-106. PubMed ID: 12472772 [TBL] [Abstract][Full Text] [Related]
11. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy. Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257 [TBL] [Abstract][Full Text] [Related]
12. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Jacobson JR; Dudek SM; Birukov KG; Ye SQ; Grigoryev DN; Girgis RE; Garcia JG Am J Respir Cell Mol Biol; 2004 May; 30(5):662-70. PubMed ID: 14630613 [TBL] [Abstract][Full Text] [Related]
13. Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function. Kaneider NC; Egger P; Dunzendorfer S; Wiedermann CJ Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1029-35. PubMed ID: 12067916 [TBL] [Abstract][Full Text] [Related]
14. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin. Xu H; Liu P; Liang L; Danesh FR; Yang X; Ye Y; Zhan Z; Yu X; Peng H; Sun L Arthritis Rheum; 2006 Nov; 54(11):3441-51. PubMed ID: 17075836 [TBL] [Abstract][Full Text] [Related]
15. HS1 deficiency impairs neutrophil recruitment in vivo and activation of the small GTPases Rac1 and Rap1. Latasiewicz J; Artz A; Jing D; Blanco MP; Currie SM; Avila MV; Schnoor M; Vestweber D J Leukoc Biol; 2017 May; 101(5):1133-1142. PubMed ID: 28122813 [TBL] [Abstract][Full Text] [Related]
17. Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. Eccles KA; Sowden H; Porter KE; Parkin SM; Homer-Vanniasinkam S; Graham AM Atherosclerosis; 2008 Sep; 200(1):69-79. PubMed ID: 18486135 [TBL] [Abstract][Full Text] [Related]
18. The effect of simvastatin treatment on endothelial cell response to shear stress and tumor necrosis factor alpha stimulation. Dick M; MacDonald K; Tardif JC; Leask RL Biomed Eng Online; 2015 Jun; 14():58. PubMed ID: 26091905 [TBL] [Abstract][Full Text] [Related]
19. TNF induces caspase-dependent inflammation in renal endothelial cells through a Rho- and myosin light chain kinase-dependent mechanism. Wu X; Guo R; Chen P; Wang Q; Cunningham PN Am J Physiol Renal Physiol; 2009 Aug; 297(2):F316-26. PubMed ID: 19420112 [TBL] [Abstract][Full Text] [Related]